<p>Therapeutic efficiency of general administration of cyclophosphamide in the control group.</p
<p>Dosing strategies for orally administrated drugs for GBM from published clinical trials.</p
<p>First-line chemotherapy regimens administered in the three groups of patients.</p
<p>Efficacy of active periodontal therapy versus inactive control on post-treatment CRP values.</p
<p>Number of implanted CapCell and dosage of cyclophosphamide in the study group.</p
<p>(a) small tumor group; (b) large tumor group. E-PA = estimated treatment time of PA; A-PA = actua...
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
Funnel plot of effectiveness rate in the treatment group and the control group.</p
<p>Assessment of the treatment effect (treatment group) on cytokines in patients with available data...
<p>Overall Survival by type of therapy in patients with ECOG performance status of 0.</p
<p>Comparative efficacy of biological agents for induction and maintenance therapy for anti-TNF ther...
<p>Distribution of the characteristics of the study population by groups, intervention (tranexamic a...
<p>Overall survival time between different chemotherapy treatments in the combination group.</p
<p>The breakdown of optimal treatments as a function of the potency of the NaP antagonist .</p
Cyclophosphamide (CPA) is one of the most broadly used anticancer agents. CPA is also a potent immun...
Growth performance parameters of pigs in either control (CON) or sub-therapeutic chlortetracycline (...
<p>Dosing strategies for orally administrated drugs for GBM from published clinical trials.</p
<p>First-line chemotherapy regimens administered in the three groups of patients.</p
<p>Efficacy of active periodontal therapy versus inactive control on post-treatment CRP values.</p
<p>Number of implanted CapCell and dosage of cyclophosphamide in the study group.</p
<p>(a) small tumor group; (b) large tumor group. E-PA = estimated treatment time of PA; A-PA = actua...
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
Funnel plot of effectiveness rate in the treatment group and the control group.</p
<p>Assessment of the treatment effect (treatment group) on cytokines in patients with available data...
<p>Overall Survival by type of therapy in patients with ECOG performance status of 0.</p
<p>Comparative efficacy of biological agents for induction and maintenance therapy for anti-TNF ther...
<p>Distribution of the characteristics of the study population by groups, intervention (tranexamic a...
<p>Overall survival time between different chemotherapy treatments in the combination group.</p
<p>The breakdown of optimal treatments as a function of the potency of the NaP antagonist .</p
Cyclophosphamide (CPA) is one of the most broadly used anticancer agents. CPA is also a potent immun...
Growth performance parameters of pigs in either control (CON) or sub-therapeutic chlortetracycline (...
<p>Dosing strategies for orally administrated drugs for GBM from published clinical trials.</p
<p>First-line chemotherapy regimens administered in the three groups of patients.</p
<p>Efficacy of active periodontal therapy versus inactive control on post-treatment CRP values.</p
DOI
Add to ORKG